[Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
The object of this study was to value the efficacy of reflux oesophagitis treatment by H2-blockers. Fifty-one patients were treated by Cimetidine or Ranitidine. After three months, we note a clinical improvement in 84% of cases and a regression of the endoscopic lesions in 61% of cases. A long term overlooking shows a high number of recurrences when the treatment is stopped, whereas the chronic treatment has essentially a stabilizing effect on the lesions.